Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 2.1 (5-Year IF – 2.0)
Journal Citation Indicator (JCI) (2023) – 0.4
Scopus CiteScore – 3.7 (CiteScore Tracker – 4.0)
Index Copernicus  – 171.00; MNiSW – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2018, vol. 27, nr 5, May, p. 643–648

doi: 10.17219/acem/85081

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Detection of Brucella abortus by immunofluorescence assay using anti outer membrane protein of 19 kDa antibody

Elham Mohammadi1,A,C,D, Mehdi Golchin2,A,D,E,F

1 Division of Microbiology, Department of Pathobiology, Faculty of Veterinary Medicine, Shahid Bahonar University of Kerman, Iran

2 Department of Pathobiology, Faculty of Veterinary Medicine, Shahid Bahonar University of Kerman, Iran

Abstract

Background. Brucellosis in humans is one of the most prevalent zoonotic diseases around the world with more than 500,000 new cases per year. It is a weakening disease that requires long-term antibiotic treatment, often resulting in permanent and disabling consequences. Outer membrane proteins (OMPs) of Brucella, which are non-lipopolysaccharide (LPS) antigens, have been used for the diagnostic kits of brucellosis and vaccine design.
Objectives. The aim of this study was to identify Brucella abortus with an immunofluorescence (IF) test using an antibody against recombinant outer membrane protein (OMP) of 19 kDa of this bacterium.
Material and Methods. The OMP19 gene of Brucella spp. was synthesized, cloned and expressed in Escherichia coli cells. The OMP19 protein was purified by metal chelate affinity chromatography and subsequently used for the immunization of rabbits to produce a polyclonal antibody. Then, this antibody was conjugated to fluorescein isothiocyanate (FITC) and used for the detection of Brucella by an IF test. Also, the sensitivity and specificity of this antibody for the diagnosis of clinical isolates was calculated.
Results. Outer membrane protein 19 was expressed well and reacted with a commercial antiserum against His-tag in an immunoblot assay. Polyclonal antibodies obtained from the serum of rabbits immunized with the purified protein showed strong reactivity in the enzyme-linked immunosorbent assay (ELISA). Moreover, the polyclonal antibody conjugated to FITC was able to properly identify Brucella abortus. Sensitivity and specificity of this IF test in comparison with a polymerase chain reaction (PCR) assay was 84.2% and 50%, respectively.
Conclusion. This high-titer antibody could potentially be valuable for the specific diagnostic test of brucellosis.

Key words

antibody, immunofluorescence assay, OMP19, Brucella abortus

References (42)

  1. Baldi PC, Giambartolomei GH, Goldbaum FA, et al. Humoral immune response against lipopolysaccharide and cytoplasmic proteins of Brucella abortus in cattle vaccinated with B. abortus S19 or experimentally infected with Yersinia enterocolitica serotype 0:9. Clin Diagn Lab Immunol. 1996;3:472–476.
  2. De Bagüés MJ, Marin C, Blasco J, Moriyon I, Gamazo C. An ELISA with Brucella lipopolysaccharide antigen for the diagnosis of B. melitensis infection in sheep and for the evaluation of serological responses following subcutaneous or conjunctival B. melitensis strain Rev 1 vaccination. Vet Microbiol. 1992;30:233–241.
  3. Raybould T. Antigens of diagnostic significance in Brucella abortus. Can J Microbiol. 1982;28:557–566.
  4. Watarai M, Kim S, Yamamoto J, et al. A rapid agglutination assay for canine brucellosis using antigen coated beads. J Vet Med Sci. 2007;69:477–480.
  5. Corbel M. Recent advances in brucellosis. J Med Microbiol. 1997;46:101–103.
  6. Delpino MV, Estein SM, Fossati CA, Baldi PC, Cassataro J. Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice. Vaccine. 2007;25:6721–6729.
  7. Morgan W, MacKinnon D, Lawson J, Cullen G. The rose bengal plate agglutination test in the diagnosis of brucellosis. Vet Rec. 1969;85:636–641.
  8. Ruiz-Mesa J, Sánchez-Gonzalez J, Reguera J, Martin L, Lopez-Palmero S, Colmenero J. Rose Bengal test: Diagnostic yield and use for the rapid diagnosis of human brucellosis in emergency departments in endemic areas. Clin Microbiol Infect. 2005;11:221–225.
  9. Christopher S, Umapathy B, Ravikumar K. Brucellosis: Review on the recent trends in pathogenicity and laboratory diagnosis. J Lab Physicians. 2010;2:55.
  10. Eskra L, Canavessi A, Carey M, Splitter G. Brucella abortus genes identified following constitutive growth and macrophage infection. Infect Immun. 2001;69:7736–7742.
  11. Lindler LE, Hadfield TL, Tall BD, et al. Cloning of a Brucella melitensis group 3 antigen gene encoding Omp28, a protein recognized by the humoral immune response during human brucellosis. Infect Immun. 1996;64:2490–2499.
  12. Smirnova EA, Vasin AV, Sandybaev NT, et al. Current methods of human and animal brucellosis diagnostics. Adv Infect Dis. 2013;3:177–184.
  13. Cloeckaert A, Baucheron S, Vizcaino N, Zygmunt MS. Use of recombinant BP26 protein in serological diagnosis of Brucella melitensis infection in sheep. Clin Diagn Lab Immunol. 2001;8:772–775.
  14. Cloeckaert A, Jacques I, Bosseray N, et al. Protection conferred on mice by monoclonal antibodies directed against outer-membrane-protein antigens of Brucella. J Med Microbiol. 1991;34:175–180.
  15. de Bagüés MJ, Elzer P, Blasco J, Marin C, Gamazo C, Winter A. Protective immunity to Brucella ovis in BALB/c mice following recovery from primary infection or immunization with subcellular vaccines. Infect Immun. 1994;62:632–638.
  16. Ficht TA, Bearden S, Sowa B, Adams L. A 36-kilodalton Brucella abortus cell envelope protein is encoded by repeated sequences closely linked in the genomic DNA. Infect Immun. 1988;56:2036–2046.
  17. Gupta V, Kumari R, Vohra J, Singh S, Vihan V. Comparative evaluation of recombinant BP26 protein for serological diagnosis of Brucella melitensis infection in goats. Small Rumin Res. 2010;93:119–125.
  18. Ko KY, Kim JW, Her M et al. Immunogenic proteins of Brucella abortus to minimize cross reactions in brucellosis diagnosis. Vet Microbiol.
  19. Sowa B, Kelly K, Ficht T, Frey M, Adams L. SDS-soluble and peptidoglycan-bound proteins in the outer membrane-peptidoglycan complex of Brucella abortus. Vet Microbiol. 1991;27:351–369.
  20. Dubray G, Bezard G. Isolation of three Brucella abortus cell-wall antigens protective in murine experimental brucellosis. Ann Rech Vet. 1980;11:367–373.
  21. Verstreate D, Creasy M, Caveney N, Baldwin C, Blab M, Winter A. Outer membrane proteins of Brucella abortus: Isolation and characterization. Infect Immune. 1982;35:979–989.
  22. Gomez-Miguel MJ, Moriyon I. Demonstration of a peptidoglycan-linked lipoprotein and characterization of its trypsin fragment in the outer membrane of Brucella spp. Infect Immune. 1986;53:678–684.
  23. Gomez-Miguel MJ, Moriyon I, Lopez J. Brucella outer membrane lipoprotein shares antigenic determinants with Escherichia coli Braun lipoprotein and is exposed on the cell surface. Infect Immune. 1987;55:258–262.
  24. Cassataro J, Pasquevich KA, Estein SM, et al. A DNA vaccine coding for the chimera BLSOmp31 induced a better degree of protection against B. ovis and a similar degree of protection against B. melitensis than Rev. 1 vaccination. Vaccine. 2007;25:5958–5967.
  25. Cloeckaert C, Jacques I, Limet J, Dubray G. Immunogenic properties of Brucella melitensis cell-wall fractions in BALB/c mice. J Med Microbiol. 1995;42:200–208.
  26. Cloeckaert A, De Wergifosse P, Dubray G, Limet J. Identification of seven surface-exposed Brucella outer membrane proteins by use of monoclonal antibodies: Immunogold labeling for electron microscopy and enzyme-linked immunosorbent assay. Infect Immune. 1990;58:3980–3987.
  27. Tibor A, Decelle B, Letesson J-J. Outer membrane proteins Omp10, Omp16, and Omp19 of Brucella spp. are lipoproteins. Infect Immune. 1999;67:4960–4962.
  28. Farahi F, Asli E, Mobarez AM, Khoramabadi N, Bakhtiari A. Recombinant Brucella abortus outer membrane protein 19 (rOmp19) significantly stimulates splenic lymphocytes of immunized BALB/c mice. Afr J Microbiol Res. 2012;6:4128–4131.
  29. Giambartolomei GH, Zwerdling A, Cassataro J, Bruno L, Fossati CA, Philipp MT. Lipoproteins, not lipopolysaccharide, are the key mediators of the proinflammatory response elicited by heat-killed Brucella abortus. J Immunol. 2004;173:4635–4642.
  30. Pasquevich KA, Estein SM, Samartino CG, et al. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection. Infect Immune. 2009;77:436–445.
  31. Pasquevich KA, IbañezAE, Coria LM, et al. An oral vaccine based on U-Omp19 induces protection against B. abortus mucosal challenge by inducing an adaptive IL-17 immune response in mice. PLoS One. 2011;6:e16203.
  32. Sidhu-Munoz RS, Sancho P, Vizcaino N. Brucella ovis PA mutants for outer membrane proteins Omp10, Omp19, SP41, and BepC are not altered in their virulence and outer membrane properties. Vet Microbiol. 2016;186:59–66.
  33. Tibor A, Saman E, de Wergifosse P, Cloeckaert A, Limet JN, Letesson JJ. Molecular characterization, occurrence, and immunogenicity in infected sheep and cattle of two minor outer membrane proteins of Brucella abortus. Infect Immun. 1996;64:100–107.
  34. Fiorentino MA, Campos E, Cravero S, et al. Protection levels in vaccinated heifers with experimental vaccines Brucella abortus M1-luc and INTA 2. Vet Microbiol. 2008;132:302–311.
  35. Sambrook J, Russell DW. Molecular Cloning: A Laboratory Manual. 3rd ed. New York, NY: Coldspring-Harbour Laboratory Press; 2001.
  36. Farshad S, Mehrabanpour M, Namavari M, Hosseini S, Tavakkoli A, Ghaderi A. Production and characterization of monoclonal antibodies against Brucella abortus S (99) surface antigens. Iran Biomed J. 2002;6:7–12.
  37. Zheng W, Wang Y, Zhang Z, Yan F. Immunological characteristics of outer membrane protein omp31 of goat Brucella and its monoclonal antibody. Genet Mol Res. 2015;14:11965.
  38. Ghasemi A, Salari MH, Zarnani AH, et al. Immune reactivity of Brucella melitensis-vaccinated rabbit serum with recombinant Omp31 and DnaK proteins. Iran J Microbiol. 2013;5:19–23.
  39. Riezu-Boj JI, Moriyon I, Blasco J, Gamazo C, Diaz R. Antibody response to Brucella ovis outer membrane proteins in ovine brucellosis. Infect Immune. 1990;58:489–494.
  40. Sung KY, Jung M, Shin MK, et al. Induction of immune responses by two recombinant proteins of Brucella abortus, outer membrane proteins 2b porin and Cu/Zn superoxide dismutase, in mouse model. J Microbiol Biotechnol. 2014;24:854–861.
  41. Limet J, Cloeckaert A, Bezard G, Van Broeck J, Dubray G. Antibody response to the 89-kDa outer membrane protein of Brucella in bovine brucellosis. J Med Microbiol. 1993;39:403–407.
  42. Munir R, Afzal M, Hussain M, Naqvi S, Khanum A. Outer membrane proteins of Brucella abortus vaccinal and field strains and their immune response in buffaloes. Pak Vet J. 2010;30:110–114.
© Wroclaw Medical University